Sam Brusco, Associate Editor03.28.23
Conventus Flower Orthopedics has appointed Jeff Culhane as its new chief operating officer (COO), effective immediately.
Culhane has over 25 years of executive management in the medical device industry. He most recently served as chief product officer for Precision Medical Inc. He also spent seven years with Orthofix as its VP of product development for the BioStim business unit. Prior to that tenure, Culhane led new product development for DJO Global as VP of research and development.
"Jeff's outstanding track record and proven expertise in the medical device industry will be a great addition to our current leadership team," Brad Niemann, CEO of Conventus Flower told the press. "We are excited to have him join our organization as we continue to grow our commercialized products and expand our innovative, highly differentiated technologies."
"I am thrilled to join the Conventus Flower Orthopedics team," added Culhane. "There is immense buzz around the Company's expanded Flex-Thread™ portfolio, most recently with the Flex-Thread Ulna Nail. With the momentum of the new Flex-Thread products, combined with the foundation of the legacy Ready-For-Surgery portfolio, I am excited to help further accelerate growth and a rapid, robust pipeline."
Conventus Flower received U.S. Food and Drug Administration (FDA) clearance for its Flex-Thread ulna intramedullary (IM) nail for fixation of fractures and osteotomies of the ulna in January 2023.
Culhane has over 25 years of executive management in the medical device industry. He most recently served as chief product officer for Precision Medical Inc. He also spent seven years with Orthofix as its VP of product development for the BioStim business unit. Prior to that tenure, Culhane led new product development for DJO Global as VP of research and development.
"Jeff's outstanding track record and proven expertise in the medical device industry will be a great addition to our current leadership team," Brad Niemann, CEO of Conventus Flower told the press. "We are excited to have him join our organization as we continue to grow our commercialized products and expand our innovative, highly differentiated technologies."
"I am thrilled to join the Conventus Flower Orthopedics team," added Culhane. "There is immense buzz around the Company's expanded Flex-Thread™ portfolio, most recently with the Flex-Thread Ulna Nail. With the momentum of the new Flex-Thread products, combined with the foundation of the legacy Ready-For-Surgery portfolio, I am excited to help further accelerate growth and a rapid, robust pipeline."
Conventus Flower received U.S. Food and Drug Administration (FDA) clearance for its Flex-Thread ulna intramedullary (IM) nail for fixation of fractures and osteotomies of the ulna in January 2023.